Skip to main content
SpringerLink
Log in

Ringelröteln (Parvovirus B19)

  • Chapter
  • First Online:
Infektionserkrankungen der Schwangeren und des Neugeborenen

  • 3320 Accesses

Zusammenfassung

Das Parvovirus B19 wurde erstmals 1975 in der Probe eines gesunden Blutspenders nachgewiesen. Kurz darauf stellte man fest, dass dieses Virus bei Kindern mit Sichelzellenanämie aplastische Krisen auslöst. Im Jahr 1983 gelang es, das Parvovirus B19 als Verursacher der Ringelröteln zu identifizieren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Weiterführende Literatur

  • Anderson MJ, Jones SE, Fisher-Hoch SP et al (1983) The human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (I):1378

    Google Scholar 

  • Blümel H, Schmidt I, Effenberger W et al (2002) Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42:1473–1481

    Article  PubMed  Google Scholar 

  • Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–117

    Article  PubMed  CAS  Google Scholar 

  • Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM (1984) Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii:1033–1034

    Article  Google Scholar 

  • Cossart Y-E, Cant B, Field AM, Widdows D (1975) Parvovirus like particles in human sera. Lancet I:72–73

    Article  Google Scholar 

  • Enders M, Weidner A, Zoellner I, Searle K, Enders G (2004) Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24:513–518

    Article  PubMed  Google Scholar 

  • Enders M, Schalasta G, Baisch C et al (2006) Human parvovirus B19 infection during pregnancy – value of modern molecular and serological diagnostics. J Clin Virol 35:400–406

    Article  PubMed  CAS  Google Scholar 

  • Enders M, Weidner A, Enders G (2007) Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 135:563–569

    Article  PubMed  CAS  Google Scholar 

  • Gärtner B, Enders M, Luft-Duchow C, Bocharov G, Modrow S (2007) Parvovirus B-19 infections in pregnant women in day care facilities: health economic analysis of prohibition to employ seronegative women. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:1369–1378

    Article  PubMed  Google Scholar 

  • Gratacos E, Torres PJ, Vidal J et al (1995) The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 171:1360–1363

    Article  PubMed  CAS  Google Scholar 

  • Harger JH, Adler SP, Koch WC, Harger GF (1998) Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symtoms. Obstet Gynecol 91:413–420

    Article  PubMed  CAS  Google Scholar 

  • Heegaard ED, Rosthoj S, Petersen BL et al (1999) Role of parvovirus B19 infection in childhood thrombocytopenic purpura. Acta Paediatr 88:614–617

    Article  PubMed  CAS  Google Scholar 

  • Hemauer A, Gigler A, Searle K et al (2000) Prevalence of NS1-specific antibodies in patients infected with parvovirus B19 and in pregnant women. J Med Virol 60:48–55

    Article  PubMed  CAS  Google Scholar 

  • Hsu TC, Tsay GJ (2001) Human parvovirus B19 infection in patients with systemic lupus erythematodes. Reumatol 40:152–157

    Article  CAS  Google Scholar 

  • Iwafuchi Y, Morita T, Kamimura A, Kunisada K, Ito K, Miyazaki S (2002) Acute endocapillary proliferative glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol 57:246–250

    PubMed  CAS  Google Scholar 

  • Jensen IP, Schou O, Vestergaard BF (1998) The 1994 human parvovirus B19 epidemic in Denmark: diagnostic and epidemiological experience. APMIS 106:843–848

    Article  PubMed  CAS  Google Scholar 

  • Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BF (2000) An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 107:637–643

    Article  PubMed  CAS  Google Scholar 

  • Katta R (2002) Parvovirus B19: a review. Dermatol Clin 20:333–342

    Article  PubMed  Google Scholar 

  • Kerr JR, Modrow S (2006) Human and primate parvovirus infections and associated disease. In: Berns K, Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR (Hrsg) Parvoviruses. Arnold Publishers, Hodder, London, S 385–416

    Google Scholar 

  • Koch WC, Harger JH, Barnstein B, Adler SP (1998) Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis 17:489–494

    Article  CAS  Google Scholar 

  • von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S (2003) Anti-phospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with Parvovirus B19 infection. Arthritis Rheum 48:1939–1947

    Article  Google Scholar 

  • von Landenberg P, Lehmann HW, Modrow S (2007) Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev 6:278–285

    Article  Google Scholar 

  • Langnas AN, Markin RS, Cattral MS, Naides SJ (1995) Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anaemia. Hepatol 22:1661–1665

    CAS  Google Scholar 

  • Lehmann HW, von Landenberg P, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev2:218–223

    Google Scholar 

  • Miller E, Fairley C, Cohen BJ, Seng C (1998) Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynecol 105:174–178

    Article  CAS  Google Scholar 

  • Moore TL (2000) Parvovirus-associated arthritis. Curr Oprin Rheumatol 12:289–294

    Article  CAS  Google Scholar 

  • Naides SJ (1987) Transient liver enzymes abnormalities in acute human parvovirus B19 infection. Clinical Res 35:859

    Google Scholar 

  • Norja P, Hokynar K, Aaltonen LM et al (2006) Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103:7450–7453

    Article  PubMed  CAS  Google Scholar 

  • Public health laboratory service working party on fifth disease (1990) Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 300:1166–1170

    Article  Google Scholar 

  • Rodis JF, Borgida AF, Wilson M et al (1998) Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the society of perinatal obstetricians. Am J Obstet Gynecol 179:985–988

    Article  PubMed  CAS  Google Scholar 

  • Röhrer C, Gärtner B, Sauerbrei A et al (2008) Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 1136:1564–1575

    Article  Google Scholar 

  • Sokal EM, Melchior M, Cornu C et al (1998) Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 352:1739–1741

    Article  PubMed  CAS  Google Scholar 

  • Valeur-Jensen AK, Pedersen CB, Westergaard T et al (1999) Risk factors for parvovirus B19 infection in pregnancy. JAMA 281:1099–1105

    Article  PubMed  CAS  Google Scholar 

  • Yaegashi N, Niinuma T, Chisaka H et al (1998) The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 37:28–35

    Article  PubMed  CAS  Google Scholar 

  • Yaegashi N, Niinuma T, Chisaka H et al (1999) Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 38:30–35

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Deutschland

    Susanne Modrow Prof. Dr. rer. nat.

Authors
  1. Susanne Modrow Prof. Dr. rer. nat.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik u. Poliklinik f. Frauenheilkunde, und Geburtshilfe, Ludwig-Maximilians-Universität München, Maistraße 11, München, 80337, Germany

    Klaus Friese

  2. Klinikum Innenstadt, Klinik für Geburtshilfe, Ludwig-Maximilians-Universität München, Maistr. 11, München, 80337, Germany

    Ioannis Mylonas

  3. Neonato. im Perinatalzen. Großhadern, Dr. von Haunerschen Kinderspital, Universitätsklinikum München, Marchioninistr. 15, München, 81377, Germany

    Andreas Schulze

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Modrow, S. (2013). Ringelröteln (Parvovirus B19). In: Friese, K., Mylonas, I., Schulze, A. (eds) Infektionserkrankungen der Schwangeren und des Neugeborenen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78325-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78325-1_16

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78324-4

  • Online ISBN: 978-3-540-78325-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation